Nanobiotix S.A. (NASDAQ:NBTX – Get Free Report) shares traded down 1% on Friday . The stock traded as low as $2.82 and last traded at $2.83. 44,226 shares changed hands during trading, an increase of 18% from the average session volume of 37,454 shares. The stock had previously closed at $2.86.
Nanobiotix Trading Down 1.0 %
The company has a fifty day simple moving average of $3.38 and a two-hundred day simple moving average of $4.52.
About Nanobiotix
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Featured Stories
- Five stocks we like better than Nanobiotix
- How to Invest in the FAANG Stocks
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Which Wall Street Analysts are the Most Accurate?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 5 discounted opportunities for dividend growth investors
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
